At the recent IMPAKT Breast Cancer Conference, 2 – 4th May, Brussels, ecancer´s Peter Goodwin talks to Ana Vivancos about her pioneering research in cancer genomics and work contributing to improved phase I clinical studies and best therapies for patients.
Related Posts
VHIO co-hosts study visit for scientific journalists across Europe
A special study visit was jointly organized by the Centre of Genomic Regulation (CRG) and the European Molecular Biology Laboratory (EMBL) as partners of the EU CommHERE Communicating European Health Research Network, in collaboration with the European Union of Science Journalists’ Associations (EUSJA)
23 May 2014
ERC´s Proof of Concept supports the Soucek lab to drive innovative Myc inhibitor to the clinic
As last year came to a close, the European Research Council (ERC) announced the 44 recipients of its highly sought-after…
07 Sep 2016
Biosimilars create opportunities for sustainable cancer care
Source: the European Society for Medical Oncology (ESMO) Lugano, Switzerland, 18 January, 2017 – Biosimilars create opportunities for sustainable cancer…
18 Jan 2017
VHIO Meet the Editors with Annals of Oncology´s Jean-Charles Soria, Monday 08 September 2014
Taking place on Monday 08 September 2014, beginning with a Welcome coffee at 14:15 – 14:30, followed by the main…
27 Jun 2014
Word Cancer Day and Declaration: "for a cancer free world"
World Cancer Day is the singular initiative under which UICC (Union for International Cancer Control), its members partners, supporters and…
25 Jan 2013
VHIO´s next Meet the Editors with Nature Medicine
Nature Medicine´s Senior Editor, Vicotria Aranda will come to VHIO Monday 17 September 2012 to deliver the 4th in the prestigious series of VHIO Meet the Editors talks.
28 Jun 2012
VHIO´s Enriqueta Felip´s expertise and international standing set to benefit the International Association for the Study of Lung Cancer
The International Association for the Study of Lung Cancer (IASLC), has recently announced ten new expert additions to its Board…
05 Jul 2017
Marketing Authorization for First-Line Treatment of Patients with Metastatic Pancreatic Cancer
First new treatment to be approved for pancreatic cancer in nearly seven years, highlighting the challenges and unmet needs in…
07 Jan 2014
Marking melanoma cancer awareness month: Vall d´Hebron updates on its multidisciplinary and purely translational approach to more effectively treating this tumor type
The incidence of melanoma skin cancers has been substantially increasing over the past decades with an estimated 132,000 cases occurring…
23 May 2017
Trio of VHIO talents awarded by AECC for research aimed at advancing cancer science and novel therapeutic approaches
Earlier this month the Spanish Association against Cancer (AECC) announced the results of its most recent Call. Among the awarded…
21 Jul 2017
In The Lancet Oncology today: leading experts explore the potential impact of ´Brexit´ on cancer research and care across Europe
In a duo of commentaries plus an accompanying editorial published ahead of print today in The Lancet Oncology, experts explore…
27 Apr 2016
Breast cancer diagnosed during pregnancy: safely treatable without harming foetal development
Cristina Saura, Principal Investigator of VHIO´s Breast Cancer and Melanoma Group, today reported important findings during her thesis defence directed…
21 Jul 2017
Announced today: Joan Seoane receives the Vanguardia de la Ciencia prize
The Spanish periodical La Vanguardia has today announced the winner, as voted by its readers, of this year´s Vanguardia de…
06 Mar 2016
Call Now Open: Applications for Oncology Research Fellowship (2) at the Mass General Hospital Cancer Center, USA
CALL FOR APPLICATIONS 2012 The objective of the Fellowship is to provide support to two outstanding MD’s, PhD’s, or MD/PhD’s…
16 Apr 2012
Multi-center study led by CIC bioGUNE reveals metabolic pathway implicated in prostate cancer growth
Published in Nature journal today, a multi-center study led by CIC bioGUNE´s Arkaitz Carracedo, Ikerbasque Research Professor, Associate Professor at the…
29 Jun 2017
